(Q40414462)
Statements
1 reference
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years (English)
1 reference
1 reference
Giovanni Martinelli
1 reference
Anna Candoni
1 reference
Eleonora Toffoletti
1 reference
Alexia Chiarvesio
1 reference
Michele Malagola
1 reference
Pier Paolo Piccaluga
1 reference
Angela Michelutti
1 reference
Erica Simeone
1 reference
Daniela Damiani
1 reference
Domenico Russo
1 reference
Renato Fanin
1 reference
14 July 2008
1 reference
1 reference
32
1 reference
12
1 reference
1800-1808
1 reference
Identifiers
1 reference
1 reference